|
Volumn 10, Issue 5, 2008, Pages 320-324
|
New quality assurance standards for rare disease testing
|
Author keywords
[No Author keywords available]
|
Indexed keywords
GENE PRODUCT;
GENOMIC DNA;
REAGENT;
ALLELE;
ALTRUISM;
CERTIFICATION;
CLINICAL GENETICS;
CLINICAL LABORATORY;
CONSULTATION;
DENATURING HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;
DIAGNOSTIC ERROR;
DIAGNOSTIC PROCEDURE;
DNA ISOLATION;
DNA SEQUENCE;
EXPERIENCE;
GENETIC ANALYSIS;
GENETIC COUNSELING;
GENETIC DISORDER;
GENETIC PROCEDURES;
HETEROZYGOTE;
HUMAN;
HUMAN GENOME;
LABORATORY TEST;
LICENSING;
MOLECULAR GENETICS;
MUTATIONAL ANALYSIS;
NOTE;
PATHOLOGY;
PHENOTYPE;
PRACTICE GUIDELINE;
PROFESSIONAL KNOWLEDGE;
QUALITY CONTROL;
RARE DISEASE;
RELIABILITY;
STANDARD;
VALIDATION PROCESS;
DNA MUTATIONAL ANALYSIS;
GENETIC DISEASES, INBORN;
GENETIC SERVICES;
GENETIC TECHNIQUES;
HUMANS;
PRACTICE GUIDELINES AS TOPIC;
QUALITY CONTROL;
RARE DISEASES;
UNITED STATES;
|
EID: 44449114294
PISSN: 10983600
EISSN: None
Source Type: Journal
DOI: 10.1097/GIM.0b013e31817283ba Document Type: Note |
Times cited : (10)
|
References (7)
|